EDGAR Filing Documents for 0001654954-17-004568

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001654954-17-004568

Filing Date

2017-05-12

Accepted

2017-05-12 15:40:28

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	sbfm_10q.htm	10-Q	467003
2	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex311.htm	EX-31.1	12194
3	CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF	sbfm_ex312.htm	EX-31.2	11564
4	CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE	sbfm_ex32.htm	EX-32	6719
5	IMAGE	fig1.jpg	GRAPHIC	13383
6	IMAGE	fig2.jpg	GRAPHIC	10327
7	IMAGE	fig3.jpg	GRAPHIC	11622
8	IMAGE	fig4.jpg	GRAPHIC	15417
	Complete submission text file	0001654954-17-004568.txt		1399660

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	sbfm-20170331.xml	EX-101.INS	81725
10	XBRL TAXONOMY EXTENSION SCHEMA	sbfm-20170331.xsd	EX-101.SCH	17235
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sbfm-20170331_cal.xml	EX-101.CAL	32712
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sbfm-20170331_def.xml	EX-101.DEF	18352
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sbfm-20170331_lab.xml	EX-101.LAB	111759
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sbfm-20170331_pre.xml	EX-101.PRE	82853

Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4

Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)